Drug Profile
Research programme: cancer therapy - Digital Gene Technologies
Latest Information Update: 22 Sep 2006
Price :
$50
*
At a glance
- Originator Digital Gene Technologies
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 18 May 2001 New profile
- 18 May 2001 Preclinical development for Cancer in USA (Unknown route)